Julianne M. O’Daniel

发表

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Marc S. Williams, R. Green, R. Nussbaum, 2013, Genetics in Medicine.

Whole-Genome and Whole-Exome Sequencing in Hereditary Cancer: Impact on Genetic Testing and Counseling

Julianne M. O’Daniel, Kristy Lee, 2012, Cancer journal.

A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories

Joshua L. Deignan, W. Chung, N. Spinner, 2016, Genetics in Medicine.

Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the Clinical Genome Resource

J. Michael Cherry, Heidi L. Rehm, Erin Rooney Riggs, 2017, bioRxiv.

Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the Clinical Genome Resource

J. Michael Cherry, Avni Santani, Heidi L. Rehm, 2017, bioRxiv.

The who, what and why of research participants’ intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study

G. Henderson, James P Evans, J. Berg, 2017, Genetics in Medicine.

Referencing BRCA in hereditary cancer risk discussions: In search of an anchor in a sea of uncertainty

J. Berg, Julianne M. O’Daniel, A. K. Foreman, 2020, Journal of genetic counseling.

Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing

K. Ormond, Julianne M. O’Daniel, B. Bernhardt, 2018, Journal of Genetic Counseling.

A Genetic Counselor’s Guide to Using Next-Generation Sequencing in Clinical Practice

Kristy Lee, Julianne M. O’Daniel, Kristy Lee, 2014, Journal of Genetic Counseling.

CORRIGENDUM: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Heidi L Rehm, Jonathan S Berg, Leslie G Biesecker, 2017, Genetics in Medicine.

Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing

Julianne M. O’Daniel, R. Agans, S. Haga, 2011, The Pharmacogenomics Journal.

The Prospect of Genome-guided Preventive Medicine: A Need and Opportunity for Genetic Counselors

Julianne M. O’Daniel, 2010, Journal of Genetic Counseling.

Process in Genetic Counseling: Considerations for Children and Their Families

Julianne M. O’Daniel, A. McConkie-Rosell, 2010 .

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions

Julianne M. O’Daniel, R. Agans, S. Haga, 2011, Genetics in Medicine.

A review and definition of ‘usual care’ in genetic counseling trials to standardize use in research

Sarah E Lillie, Marian J. Gilmore, Julianne M. O’Daniel, 2020, Journal of genetic counseling.

Factors influencing NCGENES research participants’ requests for non-medically actionable secondary findings

G. Henderson, James P Evans, J. Berg, 2018, Genetics in Medicine.

Public perspectives about pharmacogenetic testing and managing ancillary findings.

Julianne M. O’Daniel, S. Haga, G. Tindall, 2012, Genetic testing and molecular biomarkers.

Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial

Tamara S. Roman, J. Berg, Julianne M. O’Daniel, 2021, Trials.

Which came first: validity or clinical testing? The example of long QT genes

J. Berg, Julianne M. O’Daniel, A. K. Foreman, 2018 .

The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation

G. Henderson, R. J. Cadigan, J. Berg, 2022, Journal of personalized medicine.

Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making

J. Berg, Julianne M. O’Daniel, C. Powell, 2021, Genome medicine.

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design

G. Ginsburg, Julianne M. O’Daniel, Kensaku Kawamoto, 2012, BMC Health Services Research.

Genetic Testing, Psychological Implications

Julianne M. O’Daniel, 2020, Encyclopedia of Behavioral Medicine.

Enhancing geneticists’ perspectives of the public through community engagement

L. Boles, Julianne M. O’Daniel, S. Haga, 2012, Genetics in Medicine.

Genetic Library: Genetics and Public Health

Julianne M. O’Daniel, Barbara Lerner, M. Roche, 2004, Journal of Genetic Counseling.

Genomic Knowledge in the Context of Diagnostic Exome Sequencing: Changes over Time, Persistent Subgroup Differences, and Associations with Psychological Sequencing Outcomes

G. Henderson, J. Berg, Julianne M. O’Daniel, 2019, Genetics in Medicine.

Is Incidental Finding the Best Term? A Study of Patients’ Preferences

B. Wilfond, G. Henderson, Julianne M. O’Daniel, 2016, Genetics in Medicine.

Variant interpretation is a component of clinical practice among genetic counselors in multiple specialties

Danielle R Azzariti, B. Lepore, Julianne M. O’Daniel, 2019, Genetics in Medicine.

Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)

Lora J. H. Bean, W. Chung, H. Rehm, 2021, Genetics in Medicine.

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation

Sheri D Schully, Katrina A B Goddard, Alan F Scott, 2016, Genetics in Medicine.

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing

J. Berg, Julianne M. O’Daniel, Kristy Lee, 2015, Genetics in Medicine.

Evidence‐based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group

Elizabeth M Webber, Elizabeth M. Webber, Meredith A. Weaver, 2018, Human mutation.

Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium.

Ebony B Madden, Ebony B. Madden, Kathleen F. Mittendorf, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Approaching Complex Cases With a Crisis Intervention Model and Teamwork

Julianne M. O’Daniel, Deborah Wells, 2002, Journal of Genetic Counseling.

Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.

Tamara S. Roman, J. Berg, Julianne M. O’Daniel, 2020, American journal of human genetics.

Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings

Lisle E. Mose, D. Hayes, J. Parker, 2016, Clinical Cancer Research.

Secondary findings: How did we get here, and where are we going?

K. Ormond, Sarah S Kalia, Julianne M. O’Daniel, 2019, Journal of genetic counseling.

An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening.

J. Berg, Julianne M. O’Daniel, C. Powell, 2019, The Journal of pediatrics.

Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling

G. Ginsburg, Julianne M. O’Daniel, S. Haga, 2011, Journal of General Internal Medicine.

ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines

Diane B. Zastrow, Helio A. Costa, Marina T. DiStefano, 2022, Genome Medicine.

ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines

Diane B. Zastrow, Helio A. Costa, Marina T. DiStefano, 2021, medRxiv.

TRIG on TRACK: educating pathology residents in genomic medicine.

Julianne M. O’Daniel, V. Speights, Joan Scott, 2012, Personalized medicine.

Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomics Professionals

H. Willard, Julianne M. O’Daniel, S. Haga, 2010, Journal of Genetic Counseling.

Parental Guidance Suggested: Engaging Parents as Partners in Research Studies of Genomic Screening for a Pediatric Population

Julianne M. O’Daniel, L. Milko, G. Byfield, 2022, Frontiers in Genetics.

Parents’ perceptions of personal utility of exome sequencing results

G. Henderson, J. Berg, Julianne M. O’Daniel, 2019, Genetics in Medicine.

Application of a framework to guide genetic testing communication across clinical indications

K. Ormond, Julianne M. O’Daniel, Maureen E. Smith, 2021, Genome Medicine.

Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium

L. Hindorff, B. Wilfond, Julianne M. O’Daniel, 2021, Journal of Clinical and Translational Science.

Genomic Sequencing Results Disclosure in Diverse and Medically Underserved Populations: Themes, Challenges, and Strategies from the CSER Consortium

Julianne M. O’Daniel, Shannon Rego, Marian Gilmore, 2021, Journal of personalized medicine.

A missing link in the bench-to-bedside paradigm: engaging regulatory stakeholders in clinical genomics research

J. Berg, Julianne M. O’Daniel, 2016, Genome Medicine.

Professional perspectives about pharmacogenetic testing and managing ancillary findings.

Susanne B Haga, Julianne M O'Daniel, Julianne M. O’Daniel, 2012, Genetic testing and molecular biomarkers.

The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).

S. Fullerton, Julianne M. O’Daniel, B. Evans, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic Odyssey

R. J. Cadigan, J. Berg, Julianne M. O’Daniel, 2022, Physical & occupational therapy in pediatrics.

Burden or benefit? Effects of providing education about and the option to request additional genomic findings from diagnostic exome sequencing: A randomized controlled trial.

G. Henderson, J. Berg, Julianne M. O’Daniel, 2021, Patient education and counseling.

The who, what and why of research participants’ intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study

G. Henderson, J. Berg, Julianne M. O’Daniel, 2017, Genetics in Medicine.

Examining the Cascade of Participant Attrition in a Genomic Medicine Research Study: Barriers and Facilitators to Achieving Diversity

G. Henderson, J. Berg, Julianne M. O’Daniel, 2018, Public Health Genomics.

Parents’ perceptions of personal utility of exome sequencing results

G. Henderson, J. Berg, Julianne M. O’Daniel, 2019, Genetics in Medicine.

Engaging community stakeholders in research on best practices for clinical genomic sequencing

J. Berg, Julianne M. O’Daniel, C. Rini, 2020, Personalized medicine.

Variant Interpretation is a Component of Clinical Practice Among Genetic Counselors in Multiple Specialties

Danielle R Azzariti, B. Lepore, C. Martin, 2019, Genetics in Medicine.

Promoting Public Awareness and Engagement in Genome Sciences

L. Boles, Julianne M. O’Daniel, S. Haga, 2013, Journal of Genetic Counseling.

Factors influencing NCGENES research participants’ requests for non-medically actionable secondary findings

G. Henderson, J. Berg, Julianne M. O’Daniel, 2018, Genetics in Medicine.

Public Perspectives on Returning Genetics and Genomics Research Results

Julianne M. O’Daniel, S. Haga, S. Haga, 2011, Public Health Genomics.

Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing

Julianne M. O’Daniel, R. Agans, S. Haga, 2011, The Pharmacogenomics Journal.

Is Incidental Finding the Best Term? A Study of Patients’ Preferences

B. Wilfond, G. Henderson, Julianne M. O’Daniel, 2016, Genetics in Medicine.